Henan Taloph Pharmaceutical Stock Co.,Ltd (SHA:600222)
7.30
-0.13 (-1.75%)
Mar 11, 2026, 10:45 AM CST
SHA:600222 Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 10, 2026 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Market Capitalization | 4,108 | 2,823 | 3,429 | 3,544 | 5,056 | 2,735 | Upgrade
|
| Market Cap Growth | 40.81% | -17.66% | -3.25% | -29.90% | 84.84% | 9.21% | Upgrade
|
| Enterprise Value | 4,746 | 3,456 | 3,965 | 3,814 | 5,742 | 3,210 | Upgrade
|
| Last Close Price | 7.43 | 5.08 | 6.08 | 6.32 | 8.89 | 4.95 | Upgrade
|
| PE Ratio | 87.60 | 55.88 | 78.72 | - | 843.33 | 93.55 | Upgrade
|
| PS Ratio | 2.30 | 1.45 | 1.66 | 1.81 | 3.15 | 1.93 | Upgrade
|
| PB Ratio | 2.49 | 1.74 | 2.11 | 2.20 | 2.84 | 1.79 | Upgrade
|
| P/TBV Ratio | 3.27 | 2.28 | 2.77 | 2.87 | 3.83 | 2.47 | Upgrade
|
| P/FCF Ratio | - | - | 5673.80 | - | 83.46 | 3529.88 | Upgrade
|
| P/OCF Ratio | - | - | 78.40 | - | 50.74 | 37.25 | Upgrade
|
| EV/Sales Ratio | 2.65 | 1.78 | 1.92 | 1.95 | 3.58 | 2.27 | Upgrade
|
| EV/EBITDA Ratio | 29.47 | 27.17 | 31.16 | 96.86 | 33.91 | 27.29 | Upgrade
|
| EV/EBIT Ratio | 49.15 | 45.53 | 52.21 | - | 45.81 | 42.12 | Upgrade
|
| EV/FCF Ratio | -66.18 | - | 6560.68 | - | 94.77 | 4142.80 | Upgrade
|
| Debt / Equity Ratio | 0.56 | 0.63 | 0.48 | 0.41 | 0.69 | 0.87 | Upgrade
|
| Debt / EBITDA Ratio | 5.74 | 7.30 | 5.42 | 12.08 | 6.71 | 11.26 | Upgrade
|
| Debt / FCF Ratio | - | - | 1290.72 | - | 20.22 | 1709.07 | Upgrade
|
| Net Debt / Equity Ratio | 0.35 | 0.47 | 0.27 | 0.17 | 0.31 | 0.41 | Upgrade
|
| Net Debt / EBITDA Ratio | 3.93 | 6.01 | 3.38 | 7.10 | 3.30 | 5.35 | Upgrade
|
| Net Debt / FCF Ratio | -8.10 | -9.96 | 711.63 | -1.46 | 9.22 | 812.50 | Upgrade
|
| Asset Turnover | 0.48 | 0.55 | 0.58 | 0.53 | 0.45 | 0.45 | Upgrade
|
| Inventory Turnover | 2.71 | 3.50 | 3.33 | 3.59 | 3.14 | 3.23 | Upgrade
|
| Quick Ratio | 0.84 | 0.80 | 0.88 | 0.86 | 0.89 | 0.97 | Upgrade
|
| Current Ratio | 1.16 | 1.06 | 1.21 | 1.18 | 1.18 | 1.25 | Upgrade
|
| Return on Equity (ROE) | 3.31% | 3.29% | 2.77% | -4.47% | 0.41% | 1.86% | Upgrade
|
| Return on Assets (ROA) | 1.62% | 1.34% | 1.32% | -0.13% | 2.18% | 1.51% | Upgrade
|
| Return on Invested Capital (ROIC) | 4.01% | 3.42% | 3.85% | -0.37% | 5.07% | 3.46% | Upgrade
|
| Return on Capital Employed (ROCE) | 5.30% | 4.50% | 3.90% | -0.40% | 5.90% | 4.00% | Upgrade
|
| Earnings Yield | 1.14% | 1.79% | 1.27% | -2.04% | 0.12% | 1.07% | Upgrade
|
| FCF Yield | -1.75% | -2.72% | 0.02% | -5.39% | 1.20% | 0.03% | Upgrade
|
| Dividend Yield | 0.38% | 0.55% | 0.30% | - | 0.11% | 0.32% | Upgrade
|
| Payout Ratio | 117.49% | 136.70% | 115.18% | - | 1410.34% | 223.89% | Upgrade
|
| Buyback Yield / Dilution | 0.64% | 1.12% | -0.07% | -0.36% | -2.52% | 1.68% | Upgrade
|
| Total Shareholder Return | 1.02% | 1.67% | 0.22% | -0.36% | -2.40% | 2.00% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.